Bruce, Matthew R. http://orcid.org/0000-0002-6943-1410
Couch, Amalie C. M.
Grant, Simone
McLellan, Janna
Ku, Katherine
Chang, Christina
Bachman, Angelica
Matson, Matthew
Berman, Robert F.
Maddock, Richard J. http://orcid.org/0000-0001-6392-5519
Rowland, Douglas http://orcid.org/0000-0001-8059-6905
Kim, Eugene http://orcid.org/0000-0003-0066-7051
Ponzini, Matthew D.
Harvey, Danielle
Taylor, Sandra L.
Vernon, Anthony C. http://orcid.org/0000-0001-7305-1069
Bauman, Melissa D.
Van de Water, Judy http://orcid.org/0000-0003-1193-5875
Funding for this research was provided by:
Nancy Lurie Marks Family Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (2P01ES011269-11, R01ES015359)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD103526)
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences
Landreth Foundation
Article History
Received: 15 August 2022
Revised: 23 February 2023
Accepted: 27 February 2023
First Online: 27 March 2023
Competing interests
: JVW has a patent application involving the MAR-ASD peptides described herein and has a UC Davis-based startup company focusing on the development of the MAR-ASD autoantibody profile as a risk assessment for a child developing ASD. All other authors have no conflicts of interest to declare.